Here, we found that ZHX2 inhibited uptake of exogenous lipids in hepatocytes and suppressed NAFLD progression by transcriptionally repressing lipid lipase (LPL) expression. The gene discussed is LPL; the disease is metabolic dysfunction-associated steatotic liver disease.